ZA739694B - New substituted cyclopropylamines process for their preparation and pharmaceutical preparation - Google Patents

New substituted cyclopropylamines process for their preparation and pharmaceutical preparation

Info

Publication number
ZA739694B
ZA739694B ZA00739694A ZA739694A ZA739694B ZA 739694 B ZA739694 B ZA 739694B ZA 00739694 A ZA00739694 A ZA 00739694A ZA 739694 A ZA739694 A ZA 739694A ZA 739694 B ZA739694 B ZA 739694B
Authority
ZA
South Africa
Prior art keywords
preparation
new substituted
cyclopropylamines
pharmaceutical preparation
pharmaceutical
Prior art date
Application number
ZA00739694A
Other languages
English (en)
Inventor
C Malen
M Desnos
M Laubie
J Poignant
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of ZA739694B publication Critical patent/ZA739694B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/06—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms
    • C07C335/08—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/18—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA00739694A 1972-12-28 1973-12-27 New substituted cyclopropylamines process for their preparation and pharmaceutical preparation ZA739694B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5988672A GB1453703A (en) 1972-12-28 1972-12-28 Substituted cyclopropylmethylamines processes for their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
ZA739694B true ZA739694B (en) 1975-02-26

Family

ID=10484588

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00739694A ZA739694B (en) 1972-12-28 1973-12-27 New substituted cyclopropylamines process for their preparation and pharmaceutical preparation

Country Status (20)

Country Link
US (1) US3988464A (enExample)
JP (3) JPS5335949B2 (enExample)
AR (2) AR207336A1 (enExample)
AT (1) AT333272B (enExample)
BE (1) BE809179A (enExample)
CH (2) CH592641A5 (enExample)
CS (1) CS186258B2 (enExample)
DD (1) DD110869A5 (enExample)
DE (1) DE2362754C2 (enExample)
DK (1) DK145574C (enExample)
ES (1) ES421879A1 (enExample)
FI (1) FI59999C (enExample)
FR (1) FR2212143B1 (enExample)
GB (1) GB1453703A (enExample)
HU (1) HU169273B (enExample)
IL (3) IL49288A (enExample)
NL (1) NL169472C (enExample)
SE (1) SE388420B (enExample)
SU (2) SU505348A3 (enExample)
ZA (1) ZA739694B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2358890A1 (fr) * 1976-05-24 1978-02-17 Science Union & Cie Nouvelles aryl trifluoroethylamines, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2432513A1 (fr) * 1977-10-24 1980-02-29 Merieux Inst Nouveaux derives de la thiazoline et leur application comme medicaments
DE2831600A1 (de) * 1978-07-19 1980-01-31 Boehringer Sohn Ingelheim Neue substituierte 2-phenylamino-1, 3-tetrahydropyrimidine-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
FR2444673A1 (fr) * 1978-12-20 1980-07-18 Science Union & Cie Nouvelles trifluoroethylamines, leurs procedes d'obtention et leur emploi comme medicament
FR2669927B1 (fr) * 1990-11-29 1994-04-08 Adir Cie Nouveaux derives de guanidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE19716237A1 (de) 1997-04-18 1998-10-22 Basf Ag Substituierte Benzyloxyimino-Verbindungen
AUPP020297A0 (en) * 1997-11-05 1997-11-27 University Of Melbourne, The A novel receptor, and compounds which bind thereto
AU2003257418A1 (en) 2002-06-19 2004-01-06 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
US20060283363A1 (en) * 2005-06-07 2006-12-21 Wollman Albert E Potato Planter Improvement to Reduce Skips and Rolling
CA2920856C (en) 2013-08-09 2026-03-03 Ardelyx, Inc. Ph modulating compounds for inhibiting gastrointestinal phosphate uptake

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626067A (en) * 1965-07-01 1971-12-07 Du Pont Substituted oxazolines, useful as pharmaceuticals
NL128801C (enExample) * 1965-11-19
DE1670751A1 (de) * 1966-09-27 1970-12-23 Bayer Ag Verfahren zur Herstellung von 2-Phenylamino-2-oxazolinen
DE1670753A1 (de) * 1966-09-27 1970-07-16 Bayer Ag Verfahren zur Herstellung von 2-Cycloalkylaminooxazolinen
DE1670752A1 (de) * 1966-09-27 1970-12-23 Bayer Ag Verfahren zur Herstellung von 2-Phenylamino-oxazolinen

Also Published As

Publication number Publication date
SU505348A3 (ru) 1976-02-28
CH592641A5 (enExample) 1977-10-31
FR2212143A1 (enExample) 1974-07-26
AR207336A1 (es) 1976-09-30
AU6340073A (en) 1975-06-12
IL43749A (en) 1977-06-30
NL169472B (nl) 1982-02-16
CS186258B2 (en) 1978-11-30
SU591136A3 (ru) 1978-01-30
IL49288A0 (en) 1976-05-31
DK145574B (da) 1982-12-13
ES421879A1 (es) 1976-08-01
DD110869A5 (enExample) 1975-01-12
AR211914A1 (es) 1978-04-14
SE388420B (sv) 1976-10-04
JPS5422978B2 (enExample) 1979-08-10
IL49288A (en) 1977-06-30
FR2212143B1 (enExample) 1977-03-11
CH590253A5 (enExample) 1977-07-29
IL43749A0 (en) 1974-03-14
NL169472C (nl) 1982-07-16
GB1453703A (en) 1976-10-27
DE2362754C2 (de) 1985-11-21
AT333272B (de) 1976-11-10
FI59999B (fi) 1981-07-31
NL7317536A (enExample) 1974-07-02
JPS5335949B2 (enExample) 1978-09-29
FI59999C (fi) 1981-11-10
ATA1089973A (de) 1976-03-15
JPS5359665A (en) 1978-05-29
DK145574C (da) 1983-05-30
JPS504084A (enExample) 1975-01-16
DE2362754A1 (de) 1974-07-11
JPS5356664A (en) 1978-05-23
BE809179A (fr) 1974-06-27
US3988464A (en) 1976-10-26
JPS544955B2 (enExample) 1979-03-12
HU169273B (enExample) 1976-10-28

Similar Documents

Publication Publication Date Title
IL42219A0 (en) 14-hydroxymorphinan derivatives and processes for their preparation
HK53679A (en) New amines and process for their preparation
CA1017755A (en) Amines and process for their preparation
ZA731945B (en) Trifluoromethyl-salicylanilides and process for preparing them
IL43749A0 (en) Novel cyclopropylmethylamine derivatives,their production and pharmaceutical compositions containing them
IL40802A0 (en) Cephalosphorin derivatives and process for their preparation
EG11870A (en) Benzenesulfonyl-ureas and process for preparing them
HK48279A (en) Antibiotic a-2315 and process for preparation thereof
ZA734461B (en) Novel 2beta-hydroxy-3alpha-amino-steroids and derivatives thereof and the processes for their preparation
ZA734194B (en) Benzenesulfonyl-ureas and process for their preparation
ZA735249B (en) Dialkyl-phosphinyl-alkane sulfonates and process for their preparation
ZA73817B (en) New amino-propane derivatives and process for their preparation
IL42250A0 (en) New 6alpha-methylprednisolone derivatives,preparation process and pharmaceutical compositions
IL41352A0 (en) Nitroimidazolyl-triazolo-pyridazines and process for the preparation thereof
CA1026334A (en) Nitroimidazolyl-triazolo-pyridazines and process for their preparation
AU482008B2 (en) New 1-acyl-homopyrimidazole-derivatives and salts thereof and process for their preparation
IL42670A0 (en) Prostatrienoic acid derivatives and process for their preparation
IL43789A0 (en) Novel everninomicin derivatives and process for their preparation
GB1405228A (en) Cis-zearalene and its derivatives and process for their preparation
CA1008452A (en) 1-acyl-homopyrimidazole-derivatives and salts thereof and process for their preparation
ZA739409B (en) Novel everninomicin derivatives and process for their preparation
ZA737973B (en) Antidepressive compounds and process for their preparation
CA892611A (en) Ketonitriles and process for their preparation
CA896579A (en) Amino-ketones and process for their preparation
CA910918A (en) Allylaminopropanol compounds and process for their preparation